AU2002221779A1 - Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation - Google Patents

Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation

Info

Publication number
AU2002221779A1
AU2002221779A1 AU2002221779A AU2177902A AU2002221779A1 AU 2002221779 A1 AU2002221779 A1 AU 2002221779A1 AU 2002221779 A AU2002221779 A AU 2002221779A AU 2177902 A AU2177902 A AU 2177902A AU 2002221779 A1 AU2002221779 A1 AU 2002221779A1
Authority
AU
Australia
Prior art keywords
medicinal products
products according
sulfonamide
glibenclamide
biguanide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221779A
Other languages
English (en)
Inventor
Nathalie Cugnardey
Nicolas Wiernsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2002221779A1 publication Critical patent/AU2002221779A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002221779A 2000-11-22 2001-10-29 Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation Abandoned AU2002221779A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0015066 2000-11-22
FR0015066A FR2816841B1 (fr) 2000-11-22 2000-11-22 Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
PCT/EP2001/012492 WO2002041879A2 (en) 2000-11-22 2001-10-29 Antidiabetic compositions containing a biguanide and a sulfonamide

Publications (1)

Publication Number Publication Date
AU2002221779A1 true AU2002221779A1 (en) 2002-06-03

Family

ID=8856750

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002221779A Abandoned AU2002221779A1 (en) 2000-11-22 2001-10-29 Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation
AU2002222026A Abandoned AU2002222026A1 (en) 2000-11-22 2001-11-22 Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002222026A Abandoned AU2002222026A1 (en) 2000-11-22 2001-11-22 Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same

Country Status (18)

Country Link
US (1) US20040039031A1 (pl)
EP (1) EP1335731A2 (pl)
JP (1) JP2004513962A (pl)
KR (1) KR20030051858A (pl)
CN (1) CN1474696A (pl)
AU (2) AU2002221779A1 (pl)
BR (1) BR0115506A (pl)
CA (1) CA2429257A1 (pl)
CZ (1) CZ20031449A3 (pl)
FR (1) FR2816841B1 (pl)
HU (1) HUP0302620A3 (pl)
MX (1) MXPA03004431A (pl)
NO (1) NO20032287L (pl)
PL (1) PL361189A1 (pl)
RU (1) RU2003116890A (pl)
SK (1) SK6452003A3 (pl)
WO (2) WO2002041879A2 (pl)
ZA (1) ZA200304766B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
JPWO2005117855A1 (ja) * 2004-06-04 2008-04-03 興和株式会社 糖尿病の予防または治療のための薬剤
WO2007105730A1 (ja) * 2006-03-13 2007-09-20 Kyowa Hakko Kogyo Co., Ltd. インスリン抵抗性改善剤
NZ579229A (en) * 2007-01-25 2011-07-29 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
WO2009124386A1 (en) * 2008-04-07 2009-10-15 Interface Biologics Inc. Combination therapy for the treatment of bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
ES2216335T3 (es) * 1997-12-08 2004-10-16 Bristol-Myers Squibb Company Nuevas sales de metformina y procedimiento.
EP0974356B1 (en) * 1998-07-15 2003-09-24 Merck Sante Tablets comprising a combination of metformin and glibenclamide

Also Published As

Publication number Publication date
FR2816841B1 (fr) 2004-02-06
HUP0302620A3 (en) 2005-06-28
EP1335731A2 (en) 2003-08-20
PL361189A1 (pl) 2004-09-20
AU2002222026A1 (en) 2002-06-03
NO20032287D0 (no) 2003-05-21
WO2002041897A2 (fr) 2002-05-30
WO2002041897A3 (fr) 2003-05-30
MXPA03004431A (es) 2003-08-19
SK6452003A3 (en) 2003-09-11
CN1474696A (zh) 2004-02-11
US20040039031A1 (en) 2004-02-26
BR0115506A (pt) 2003-10-21
HUP0302620A2 (hu) 2003-11-28
WO2002041879A2 (en) 2002-05-30
RU2003116890A (ru) 2004-12-10
KR20030051858A (ko) 2003-06-25
NO20032287L (no) 2003-05-21
JP2004513962A (ja) 2004-05-13
ZA200304766B (en) 2004-09-20
FR2816841A1 (fr) 2002-05-24
CA2429257A1 (en) 2002-05-30
WO2002041879A3 (en) 2003-05-22
CZ20031449A3 (cs) 2003-09-17

Similar Documents

Publication Publication Date Title
RU2245709C2 (ru) Применение аналогов сибутрамина для профилактики сахарного диабета
JP5000493B2 (ja) インスリン抵抗性を治療するための製薬組成物、同製薬組成物の調製においてベタネコール及びｎ−アセチルシステインを使用する方法及び同製薬組成物を含むキット
US5929066A (en) Chromium/biotin treatment of Type II diabetes
IE57793B1 (en) Orally administerable antidiabetic compositions
US20200315993A1 (en) Combinations of adrenergic receptor agonists for the treatment of type 2 diabetes
EP1017408B1 (en) Use of tethrahydrolipstatin in the treatment of diabetes type ii
USRE39480E1 (en) Chromium/biotin treatment of type II diabetes
RU2451506C1 (ru) Комбинация для лечения сахарного диабета и его осложнений
UA70303C2 (uk) Комбінація, що містить тіазолідиндіон, засіб стимуляції секреції інсуліну та дигуанід, спосіб лікування цукрового діабету
US20040039031A1 (en) Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation
EP1857118A1 (en) Medicinal composition for treating diabetes
CN113924096A (zh) 低剂量三联组合制剂
RU2362548C1 (ru) Матричная таблетка с основой для пролонгированного высвобождения триметазидина дигидрохлорида, способ ее получения и способ лечения
WO2005084660A1 (ja) ミトコンドリア病予防と対策
WO2002049636A1 (en) An antidiabetic composition of amino acids
RU2333760C2 (ru) Твердая дозированная лекарственная форма для лечения сахарного диабета
KR20040079325A (ko) 메트포르민 및 글리부라이드의 고형 경구용 제형 및 이의제조 방법
RU2247561C1 (ru) Комбинированная фармацевтическая композиция с противотуберкулёзным действием
WO2003045387A1 (en) Pharmaceutical composition with combined active agents containing metformin and a hydroxylamine derivative
RU2449797C1 (ru) Противотуберкулезное лекарственное средство и способ лечения
JPH02172914A (ja) 抗癌剤の副作用軽減剤